Registration - Amendment
CRISPR THERAPEUTICS, INC. for CRISPR THERAPEUTICS, INC.
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Reimbursement for cell and gene therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| CASEY CALDWELL New | N/A |
Health Issues HCR
Reimbursement for cell and gene therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| CASEY CALDWELL New | N/A |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | Switzerland | Switzerland | 100.0% | $250,000 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.